E L Michelson

Clinical Features and Contemporary Management of Patients with Low and Preserved Ejection Fraction Heart Failure: Baseline Characteristics of Patients in the Candesartan in Heart failure—Assessment of Reduction in Mortality and Morbidity (CHARM) Programme

John J.V. McMurray, Jan Östergren, Michael Pfeffer et al. · European Journal of Heart Failure · 2003 · 134 citations

Medicine, Cardiology, Internal Medicine +17

Prevalence and prognostic implications of electrocardiographic left ventricular hypertrophy in heart failure: evidence from the CHARM programme

Nathaniel M. Hawkins, D Wang, John J.V. McMurray et al. · Heart · 2006 · 67 citations · Full text

Medicine, Cardiology, Internal Medicine +17

Antihypertensive Efficacy of Candesartan in Comparison to Losartan: The CLAIM Study

George L. Bakris, Alan H. Gradman, Max C. Reif et al. · Journal of Clinical Hypertension · 2001 · 52 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Metabolic syndrome and insulin resistance in the TROPHY sub-study: Contrasting views in patients with high-normal blood pressure

Brent M. Egan, Vasilios Papademetriou, Marion R. Wofford et al. · American Journal of Hypertension · 2005 · 50 citations

Medicine, Cardiology, Endocrinology +17

Comparative effects of candesartan cilexetil and losartan in patients with systemic hypertension. Candesartan Versus Losartan Efficacy Comparison (CANDLE) Study Group.

Alan H. Gradman, Alex Lewin, B T Bowling et al. · PubMed · 2002 · 38 citations

Medicine, Pharmacology, Pharmacotherapy +17